fluoxetine has been researched along with myelin basic protein in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Axtell, RC; Bhat, R; Mahapatra, S; Steinman, L | 1 |
Ahmadi, M; Alipour, M; Chehelcheraghi, F; Gholami, E; Gholami, MR; Khaksarian, M; Rezaian, J; Tavakoli, A | 1 |
2 other study(ies) available for fluoxetine and myelin basic protein
Article | Year |
---|---|
Amelioration of ongoing experimental autoimmune encephalomyelitis with fluoxetine.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; CD11b Antigen; Cell Death; Cell Proliferation; Cytokines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; fas Receptor; Female; Fluoxetine; Freund's Adjuvant; Macrophages; Membrane Potential, Mitochondrial; Mice; Mice, Transgenic; Myelin Basic Protein; Myelin Proteolipid Protein; Peptide Fragments; Receptors, Antigen, T-Cell; T-Lymphocytes | 2017 |
Effect of fluoxetine treatment on neurotoxicity induced by lysolecithin in male rats.
Topics: Animals; Brain-Derived Neurotrophic Factor; Corpus Callosum; Demyelinating Diseases; Disease Models, Animal; Fluoxetine; Forkhead Transcription Factors; Gene Expression; Lysophosphatidylcholines; Male; Myelin Basic Protein; NF-kappa B; Nitric Oxide Synthase; Oligodendrocyte Transcription Factor 2; Rats, Wistar; Tumor Necrosis Factor-alpha | 2022 |